MAP PHARMACEUTICALS INC (MAPP)

Overview Price 15.49 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $15.49 Daily Range $0.00 - $0.00 52-Week Range $10.54 - $17.35 Volume 0 Located in Mountain View, California, MAP Pharmaceuticals, Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. The Company has several proprietary product candidates in clinical development that address large market opportunities, including the two most advanced product candidates: a proprietary formulation of nebulized budesonide for the potential treatment of children with asthma, and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine. Other Resources for MAPP Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Allergan Continues at Neutral August 29, 2011 Zacks Blog: Allergan Beats, Revisits Guidance August 3, 2011 Located in Mountain View, California, MAP Pharmaceuticals, Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. The Company has several proprietary product candidates in clinical development that address large market opportunities, including the two most advanced product candidates: a proprietary formulation of nebulized budesonide for the potential treatment of children with asthma, and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine.   Brokerage Analyst Recommendations 8 Brokerage Firms Covering MAPP   Strong Buy 8 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   MAPP Ratings: BUY  SELL  HOLD MAPP Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis BUY: MAPP Company: MAP PHARMACEUTICALS INC Points: -7.03 Start Price: $11.37 Start Date: 05/31/2009 11:44 PM Neurodoc P&P Score: 99.60 Recs: promising migraine drug,Levadex popped up on earnings estimate screen Comments: 8 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Neurodoc	99.60	02/03/10	M&M boys up on healthy volume today	4	02/11/10
Zacks_Analysts	0.00	08/29/11	Allergan Continues at Neutral - Analyst Blog	0
Zacks_Analysts	0.00	10/29/10	Pepco Triumphs, Revenue Dips - Analyst Blog	0
Zacks_Analysts	0.00	07/23/09	Astra Zeneca severs ties with MAP - Analyst Blog	0

Commentary

BUY: MAP PHARMACEUTICALS INC (MAPP) Start Price: $11.37 Points: -7.03 Created: 05/31/2009 promising migraine drug,Levadex popped up on earnings estimate screen Comments: 8 | Comment Neurodoc Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Neurodoc	99.60	BUY	One to Three Years	05/31/2009	$11.37	$15.50 (-0.64%)	+36.32%	+43.36%	-7.03	view close